Memory Loss Improvement Study With Prevagen Announced For Brain Awareness Week

“ Memory Loss Improvement Study QB-0011 - Prevagen Memory Study is being announced by Quincy Bioscience for Brain Awareness Week starting March 15th. Participants in the new study are ages 40-95 experiencing some memory loss. ”

Mark Underwood Researcher and Quincy Bioscience President

Share on            

Email Friend     Contact Author

(iHealthWire.Org) – Madison, WI - Memory Loss Improvement Study QB-0011 - Prevagen® Memory Study is being announced by Quincy Bioscience for Brain Awareness Week starting March 15th. The new Prevagen Memory Loss Study (http://prevagen.com/MemoryLoss.html) will evaluate the impact of Prevagen on cognitive function and other Quality of Life measures. Participants in the study are men and women between the ages of 40-95 experiencing some memory loss who will be using the brain health dietary supplement Prevagen.

Brain Awareness Week (http://www.dana.org/brainweek) is held every March and is a global campaign to increase public awareness about the progress and benefits of brain research. Brain Awareness Week (BAW) unites the efforts of universities, hospitals, patient groups, government agencies, schools, service organizations, and professional associations worldwide in a week-long celebration of the brain. Founded and coordinated by the Dana Alliance for Brain Initiatives and European Dana Alliance for the Brain, BAW is celebrating 15 years of education and outreach about the brain.

The new memory loss study, being announced for BAW by Quincy Biosciences, will use the brain health supplement Prevagen having as its main ingredient a naturally occurring calcium-binding protein discovered in jellyfish called apoaequorin. Prevagen is the first and only product to use this active ingredient.

The study is a randomized placebo-controlled, double-blind study that will require five cognitive testing sessions during the three-month study period. The impact of Prevagen on brain cell protection will be evaluated using computer-based cognitive testing software by Cogstate, Ltd., a leading cognitive testing software company based in Melbourne, Australia.

“We are excited about the new Prevagen Memory Study. We are researching various areas in order to bring hope to people with different health challenges related to aging and memory with the goal of improving quality of life,” says Mark Underwood, Quincy Bioscience president. “Additionally, we are doing a series of educational radio shows during March Brain Awareness Week to help raise brain awareness.”